Comment on

• The pathological features and prognosis of prostate cancer detectable with current diagnostic tests.

  Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT. Ohori M, et al. J Urol. 1994 Nov;152(5 Pt 2):1714-20. doi: 10.1016/s0022-5347(17)32369-8. J Urol. 1994. PMID: 7523718
• Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).

  Epstein JI, Walsh PC, Brendler CB. Epstein JI, et al. J Urol. 1994 Nov;152(5 Pt 2):1721-9. doi: 10.1016/s0022-5347(17)32370-4. J Urol. 1994. PMID: 7523719 Review.
• The nature of prostate cancer detected through prostate specific antigen based screening.

  Smith DS, Catalona WJ. Smith DS, et al. J Urol. 1994 Nov;152(5 Pt 2):1732-6. doi: 10.1016/s0022-5347(17)32372-8. J Urol. 1994. PMID: 7523720
• Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project.

  Mettlin C, Murphy GP, Lee F, Littrup PJ, Chesley A, Babaian R, Badalament R, Kane RA, Mostofi FK. Mettlin C, et al. J Urol. 1994 Nov;152(5 Pt 2):1737-40. doi: 10.1016/s0022-5347(17)32373-x. J Urol. 1994. PMID: 7523721
• Natural history of changes in prostate specific antigen in early stage prostate cancer.

  Pearson JD, Carter HB. Pearson JD, et al. J Urol. 1994 Nov;152(5 Pt 2):1743-8. doi: 10.1016/s0022-5347(17)32375-3. J Urol. 1994. PMID: 7523722 Review.
• Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

  Miller GJ, Cygan JM. Miller GJ, et al. J Urol. 1994 Nov;152(5 Pt 2):1709-13. doi: 10.1016/s0022-5347(17)32368-6. J Urol. 1994. PMID: 7933231